Drug Shortage Report for COMBIVENT RESPIMAT
Report ID | 158115 |
Drug Identification Number | 02419106 |
Brand name | COMBIVENT RESPIMAT |
Common or Proper name | COMBIVENT RESPIMAT 4ML/60 PUFF |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | SALBUTAMOL IPRATROPIUM BROMIDE |
Strength(s) | 100MCG 20MCG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 4ML/600 PUFF |
ATC code | R03AL |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-04-07 |
Actual start date | 2022-04-07 |
Estimated end date | 2022-04-26 |
Actual end date | 2022-04-22 |
Shortage status | Resolved |
Updated date | 2022-04-23 |
Company comments | Unanticipated stock out due primarily to transportation delay of replenishment order |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-04-23 | English | Compare |
v7 | 2022-04-22 | French | Compare |
v6 | 2022-04-22 | English | Compare |
v5 | 2022-04-08 | French | Compare |
v4 | 2022-04-08 | English | Compare |
v3 | 2022-04-08 | English | Compare |
v2 | 2022-04-06 | French | Compare |
v1 | 2022-04-06 | English | Compare |
Showing 1 to 8 of 8